Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX

Background: Prostate cancer (PCa) management is moving towards patient-tailored strategies. Advances in molecular and genetic profiling of tumor tissues, integrated with clinical risk assessments, provide deeper insights into disease aggressiveness. This study aims to offer a comprehensive overview...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Eugenio Bologna, Francesco Ditonno, Leslie Claire Licari, Antonio Franco, Celeste Manfredi, Spencer Mossack, Savio Domenico Pandolfo, Cosimo De Nunzio, Giuseppe Simone, Costantino Leonardo, Giorgio Franco
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	MDPI AG 2024-03-01
Serie:	Clinics and Practice
Soggetti:	PCa genetic tests active surveillance adjuvant therapies AS aRT
Accesso online:	https://www.mdpi.com/2039-7283/14/2/39
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!